Nbc Securities, Inc. Moleculin Biotech, Inc. Transaction History

Nbc Securities, Inc.

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 03, 2023	BUY	$0.38 - $0.72 $76 - $144	200 New	200 $0

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $124M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Nbc Securities, Inc. with notifications on news.